MedTech News
.................... by Andrew Celentano

Soft ‘cyborg’ cardiac patches could improve stem cell heart repair
Heart muscle cells grown from patient stem cells—known as human induced pluripotent stem cell–derived cardiomyocytes, or hiPSC-CMs—are a promising way to repair hearts damaged by heart attacks and heart failure.

Neurovalens wins FDA nod for weight management neurostim device
Neurovalens announced that it received FDA de novo approval for Modius Lean, its non-invasive neurotechnology for weight management.

FDA clears Flow Neuroscience’s at-home depression treatment in US first
Flow Neuroscience’s at-home depression treatment device has become the first of its kind to be approved by the FDA.

FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.

SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions
GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ — ModuleMD, ranked as one of America’s fastest-growing companies on the Inc. 5000 and top-rated EHR vendor on G2, announces SkinSight™ AI, a solution that brings automation, accuracy, and consistency to one of the most manual and variable workflows in allergy care: skin test measurement and documentation.

Wearable system advances neonatal health monitoring in Ethiopia
A new, soft, all-in-one, wearable system has been designed for continuous wireless monitoring of neonatal health in low-resource settings.

A light-based modulation tool for brain plasticity opens promising avenues for treating Huntington’s disease
Synaptic plasticity—the brain’s ability to modify the connections between neurons to support learning—is one of the neural functions profoundly altered in Huntington’s disease, with a direct impact on brain function.

Plant used in folk medicine has anti-inflammatory anti-arthritic effects, study confirms
In Brazil, researchers from the Federal University of Grande Dourados (UFGD), the State University of Campinas (UNICAMP), and São Paulo State University (UNESP) have conducted a study that confirmed the safety and anti-inflammatory, analgesic, and anti-arthritic properties of the Joseph’s Coat plant (Alternanthera littoralis).